Steve Duff

803 total citations · 1 hit paper
16 papers, 497 citations indexed

About

Steve Duff is a scholar working on Epidemiology, Microbiology and Surgery. According to data from OpenAlex, Steve Duff has authored 16 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Microbiology and 3 papers in Surgery. Recurrent topics in Steve Duff's work include Bacterial Infections and Vaccines (5 papers), Respiratory viral infections research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Steve Duff is often cited by papers focused on Bacterial Infections and Vaccines (5 papers), Respiratory viral infections research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Steve Duff collaborates with scholars based in United States, Ireland and France. Steve Duff's co-authors include Michael S. Mafilios, Rodrigo Hasbun, Christine C. Ginocchio, Samuel A. Bozzette, Louise Zimmer, Joan-Miquel Balada-Llasat, Ning Rosenthal, Jessica Chung, Susan H. Wootton and Joan Miquel Balada-Llasat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

Steve Duff

16 papers receiving 485 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

<p>The burden of critical limb ischemia: a review of recent literature</p>

2019 208 citations Steve Duff, Michael S. Mafilios et al. Vascular Health and Risk Management profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Duff United States	9	204	191	125	90	76	16	497
Eun‐Ha Koh South Korea	13	93 0.5×	76 0.4×	37 0.3×	52 0.6×	66 0.9×	47	414
Keiko Oda Japan	12	114 0.6×	172 0.9×	46 0.4×	89 1.0×	32 0.4×	61	438
Malcolm M. DeCamp United States	9	157 0.8×	133 0.7×	40 0.3×	165 1.8×	58 0.8×	20	542
Raphaël Halevy Israel	12	80 0.4×	212 1.1×	15 0.1×	96 1.1×	42 0.6×	20	497
Jens Svare Denmark	20	252 1.2×	281 1.5×	69 0.6×	102 1.1×	12 0.2×	40	977
Eugene D. Strandness United States	6	262 1.3×	233 1.2×	192 1.5×	57 0.6×	12 0.2×	8	652
Ased Ali United Kingdom	14	178 0.9×	172 0.9×	32 0.3×	93 1.0×	13 0.2×	38	456
Charalampos Gogos Greece	10	69 0.3×	224 1.2×	8 0.1×	62 0.7×	65 0.9×	25	474
Geoffrey Tsaras United States	7	625 3.1×	116 0.6×	15 0.1×	36 0.4×	55 0.7×	11	920
Asuman Güzelant Türkiye	11	109 0.5×	126 0.7×	12 0.1×	73 0.8×	73 1.0×	30	346

Countries citing papers authored by Steve Duff

Since Specialization

Citations

This map shows the geographic impact of Steve Duff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Duff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Duff more than expected).

Fields of papers citing papers by Steve Duff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Duff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Duff. The network helps show where Steve Duff may publish in the future.

Co-authorship network of co-authors of Steve Duff

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Duff. A scholar is included among the top collaborators of Steve Duff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Duff. Steve Duff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rustgi, Vinod K., Steve Duff, & Mohamed I. Elsaid. (2022). Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease. Journal of Medical Economics. 25(1). 347–355. 16 indexed citations

Duff, Steve, et al.. (2021). The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with RET alterations. Journal of Managed Care & Specialty Pharmacy. 28(2). 218–231. 2 indexed citations

Watson, Crystal, et al.. (2020). Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients. PubMed. 10(1). 18–26. 3 indexed citations

Duff, Steve, et al.. (2019). The burden of critical limb ischemia: a review of recent literature. SHILAP Revista de lepidopterología. 3 indexed citations

Duff, Steve, Rodrigo Hasbun, Joan-Miquel Balada-Llasat, et al.. (2019). Economic analysis of rapid multiplex polymerase chain reaction testing for meningitis/encephalitis in adult patients. Infection. 47(6). 945–953. 10 indexed citations

Duff, Steve, et al.. (2019). <p>The burden of critical limb ischemia: a review of recent literature</p>. Vascular Health and Risk Management. Volume 15. 187–208. 208 indexed citations breakdown →

Holekamp, Nancy M., et al.. (2019). Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data. Journal of Medical Economics. 23(3). 287–296. 12 indexed citations

Hasbun, Rodrigo, Susan H. Wootton, Ning Rosenthal, et al.. (2018). Epidemiology of Meningitis and Encephalitis in Infants and Children in the United States, 2011–2014. The Pediatric Infectious Disease Journal. 38(1). 37–41. 54 indexed citations

Baykaner, Tina, et al.. (2018). Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation. Journal of Cardiovascular Electrophysiology. 29(4). 526–536. 4 indexed citations

10.

Duff, Steve, et al.. (2018). A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section. Current Medical Research and Opinion. 35(6). 975–981. 3 indexed citations

11.

Duff, Steve, Rodrigo Hasbun, Christine C. Ginocchio, et al.. (2018). Economic Analysis of Rapid Multiplex Polymerase Chain Reaction Testing for Meningitis/Encephalitis in Pediatric Patients. Future Microbiology. 13(6). 617–629. 27 indexed citations

12.

Hasbun, Rodrigo, Ning Rosenthal, Joan-Miquel Balada-Llasat, et al.. (2017). Epidemiology of Meningitis and Encephalitis in the United States, 2011–2014. Clinical Infectious Diseases. 65(3). 359–363. 109 indexed citations

13.

Hasbun, Rodrigo, Ning Rosenthal, Joan-Miquel Balada-Llasat, et al.. (2017). Epidemiology of Meningitis and Encephalitis in Infants and Children in the United States from 2011 to 2014. Open Forum Infectious Diseases. 4(suppl_1). S686–S686. 4 indexed citations

14.

Merchant, Sanjay, et al.. (2013). Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain. Clinical Therapeutics. 35(5). 659–672. 12 indexed citations

15.

Duff, Steve, et al.. (2012). PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein Occlusion. Value in Health. 15(7). A571–A572. 1 indexed citations

16.

Madhu, C, et al.. (1997). Metabolic Deesterification of Tazarotene in Human Blood and Rat and HumanLiver Microsomes. Journal of Pharmaceutical Sciences. 86(8). 972–974. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact